Symbio Email Format

Pharmaceutical ManufacturingNew York, United States51-200 Employees

Symbio is a mid-sized global therapeutic CRO focused on dermatology, aesthetics, inflammation and gastroenterology, conducting studies across Phases I through IV as well as medical-device and non-interventional research. The company is based in Port Jefferson, New York, with additional offices across New York, California, Germany, France and Australia to support its international operations. It delivers end-to-end trial management with core services performed in-house and operates a dedicated laboratory alongside a facility for topical formulation, research and development, small-scale manufacturing, and clinical packaging and labeling for all dosage forms. Symbio emphasizes long-standing relationships with clinical research sites to streamline recruitment and shorten enrollment timelines by leveraging a condensed site network.

The organization sits in the pharmaceutical manufacturing and contract research space as a full-service CRO covering the clinical trial lifecycle. In 2023, Symbio merged with Proinnovera GmbH to form Symbio Proinnovera, reflecting a strategic consolidation in dermatology-focused CRO services.

Sign up for free to view info

Company overview Employee directory